bioAffinity Technologies, Inc. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Nephros, Inc.

Star Equity Holdings, Inc.

Biomerica, Inc.

Nutriband, Inc.

bioAffinity Technologies, Inc.

Vapotherm, Inc.

Prosomnus, Inc.

Inspira Technologies Oxy B.H.N. Ltd.

Ainos, Inc.

Predictive Oncology, Inc.

Better Therapeutics, Inc.

Why is bioAffinity Technologies, Inc. ?

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

Poor long term growth as Net Sales has grown by an annual rate of 105.51% and Operating profit at -223.18% over the last 5 years
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -5.67

Negative results in Jun 25

OPERATING CASH FLOW(Y) Lowest at USD -7.68 MM
ROCE(HY) Lowest at -1,802.45%
NET SALES(Q) Lowest at USD 1.27 MM

Risky - Negative EBITDA

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -96.03%, its profits have fallen by -16.4%

Below par performance in long term as well as near term

Along with generating -96.03% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is bioAffinity Technologies, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

bioAffinity Technologies, Inc.

-94.79%

-0.01

2885.07%

S&P 500

13.22%

0.61

20.17%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

105.51%

EBIT Growth (5y)

-223.18%

EBIT to Interest (avg)

-5.67

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.17

Sales to Capital Employed (avg)

0.82

Tax Ratio

0.17%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

3.98%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

5.62

EV to EBIT

-0.86

EV to EBITDA

-0.92

EV to Capital Employed

4.95

EV to Sales

0.95

PEG Ratio

Dividend Yield

ROCE (Latest)

-573.01%

ROE (Latest)

-676.56%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bullish

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

No Trend

Mildly Bearish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company

NET PROFIT(HY)

Higher at USD -5.66 MM

-31What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at USD -7.68 MM

ROCE(HY)

Lowest at -1,802.45%

NET SALES(Q)

Lowest at USD 1.27 MM

RAW MATERIAL COST(Y)

Grown by 70.58% (YoY

OPERATING PROFIT MARGIN(Q)

Lowest at -189.24 %

PRE-TAX PROFIT(Q)

Lowest at USD -2.97 MM

NET PROFIT(Q)

Lowest at USD -3 MM

Here's what is not working for bioAffinity Technologies, Inc.

Net Sales

At USD 1.27 MM has Fallen at -47.05%

Year on Year (YoY)

MOJO Watch

Near term sales trend is extremely negative

Net Sales (USD MM)

Operating Cash Flow

Lowest at USD -7.68 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Net Sales

Lowest at USD 1.27 MM and Fallen

In each period in the last five periods

MOJO Watch

Near term sales trend is very negative

Net Sales (USD MM)

Pre-Tax Profit

At USD -2.97 MM has Fallen at -41.05%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit

At USD -3 MM has Fallen at -42.07%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)

Operating Profit Margin

Lowest at -189.24 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at USD -2.97 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit

Lowest at USD -3 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (USD MM)

Raw Material Cost

Grown by 70.58% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales